Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 11, 1996, Pages 1124-1133

  Hatva, Erika ^a   Jääskeläinen, Juha ^b   Hirvonen, Harri ^c   Alitalo, Kari ^a   Haltia, Matti ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Angiogenesis; Arteriovenous malformation; Blood vessels; Brain; Tie; VEGF

Indexed keywords

PROTEIN TYROSINE KINASE;

ADULT; ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; ARTICLE; BRAIN BLOOD FLOW; BRAIN DEVELOPMENT; CELL SPECIFICITY; CORRELATION FUNCTION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SCHOOL CHILD; VASCULAR ENDOTHELIUM;

EID: 0029826147     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199611000-00003     Document Type: Article

References (51)

1. Yasargil MG. AVM of the brain: History, embryology, pathological considerations, hemodynamics. In: Yasargil MG, ed. Microneurosurgery. New York: Thieme Medical Publishers, 1987:48IIIA
2. Perret G, Nishioka H. Arteriovenous malformations. An analysis of 545 cases of cranio-cerebral arteriovenous malformations and fistulae reported to the cooperative study. J Neurosurg 1966;25:467-90
3. Challa VR, Moody DM, Brown WR. Vascular malformations of the central nervous system. J Neuropath Exp Neurol 1995;54:609-21
4. Garretson HD. Postoperative pressure and flow changes in the feeding arteries of cerebral arteriovenous malformations. Neurosurg 1979;4:544-45
5. Garretson HD. Arteriovenous malformations. In: Rosenberg RN, Grossman RG, Schochet S, Heinz ER, Willis WE, eds. The clinical neurosciences. New York: Churchill Livingstone, 1983:III089-99
6. Robinson JR Jr., Awad IA, Zhou P, Barna BP, Estes ML. Expression of basement membrane and endothelial cell adhesion molecules in vascular malformations of the brain: Preliminary observations and working hypothesis. Neurol Res 1995;17:49-58
7. Risau W, Sariola H, Zerwes H, et al. Vasculogenesis and angiogenesis in embryonic stem-cell-derived embryoid bodies. Dev 1988;102:471-78
8. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992;267:10931-34
9. Leung DW, Cachianes G, Kuang WJ, Goeddel D, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;146:1306-9
10. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Comm 1989;161:851-58
11. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989;86:7311-15
12. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246: 1309-12
13. Connolly DT, Heuvelman DM, Nelson R, et al. Tumour vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989;84:1470-78
14. Conn G, Soderman DD, Schaeffer MT, Wile M, Hatcher VB, Thomas KA. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line. Proc Natl Acad Sci 1990;87:1323-27
15. Breier G, Albrecht U, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryogenic angiogenesis and endothelial cell differentiation. Dev 1992;114:521-32
16. Millauer B, Wizigmann-Voos S, Schnürch H, et al. High affinity VEGF binding and developmental expression suggest Flk 1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993;72: 835-46
17. Berse B, Brown LF, Van De Water L, Dvorak HF, Senger DR. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumours. Mol Biol Cell 1992;3:211-20
18. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:843-48
19. Morii K, Tanaka R, Washiyama K, Kumanishi T, Kuwano R. Expression of vascular endothelial growth factor in capillary hemangioblastoma. Biochem Biophys Res Commun 1993;194:749-55
20. Berkman RA, Merill MJ, Reinhold WC, et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993;91:153-59
21. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-62
22. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995;146:1029-39
23. Olofsson B, Pajusola K, Kaipainen A, et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996;93:2567-81
24. Joukov V, Pajusola K, Kaipainen A, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO 1996;15: 290-98
25. Wizigmann-Voos S, Breier G, Risau W, Plate KH. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 1995;55:1358-64
26. Hatva E, Kaipainen K, Mentula P, et al. Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumours. Am J Pathol 1995;146:368-78
27. Hatva E, Böhling T, Jääskeläinen J, Persico MG, Haltia M, Alitalo K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J Pathol 1996;148:763-75
28. Böhling T, Hatva E, Kujala M, Claesson-Welsh L, Alitalo K, Haltia M. Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropath Exp Neurol 1996;55: 522-27
29. Partanen J, Armstrong E, Mäkelä TP, et al. A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 1992;12:1698-1707
30. Korhonen J, Polvi A, Partanen J, Alitalo K. The mouse Tie receptor tyrosine kinase gene: Expression during embryonic angiogenesis. Oncogene 1993;8:395-403
31. Korhonen J, Partanen J, Armstrong E, et al. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularisation. Blood 1992;80:2548-55
32. Puri MC, Rossant J, Alitalo K, Bernstein A, Partanen J. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO 1995;14:5884-91
33. Kaipainen A, Vlaykova T, Hatva E, et al. Enhanced expression of the Tie receptor tyrosine kinase messenger RNA in the vascular endothelium of metastatic melanomas. Cancer Res 1994;54: 6571-77
34. Hirvonen H, Mäkelä TP, Sandberg M, Kalimo H, Vuorio E, Alitalo K. Expression of the myc proto-oncogenes in developing human fetal brain. Oncogene 1990;5:1787-97
35. Hirvonen H, Salonen R, Sandberg M, Vuorio E, Kotilainen E, Kalimo H. Differential expression of myc, max and RBI mRNAs in human gliomas and glioma cell lines. Br J Cancer 1994;69:19-29
36. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979;18:5294-99
37. Wilkinson DG, Bailes JA, McMahon AP Expression of the protooncogene int-1 is restricted to specific neural cells in the developing mouse embryo. Cell 1987;50:79-88
38. Wilkinson DG, Bailes JA, Champion JE, McMahon AP. A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression. Development 1987;99:493-500
39. Jaffe EA, Hoyer LW, Nachman RL. Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci USA 1974;71:1906-9
40. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasms. Am J Clin Pathol 1991;96:25-31
41. Ferrara N, Houck KA, Jakeman L, Winer J, Leung DW. The vascular endothelial growth factor family of polypeptides. J Cell Biochem 1991;47:211-18
42. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi B-Z. Vascular endothelial growth factor and its receptors. Prog Growth Fact Res 1994;5:89-97
43. Hamilton MG, Spetzler RF. The prospective application of a grading system for arteriovenous malformations. Neurosurg 1994;34: 2-7
44. Schweitzer JS, Chang BS, Madsen P, et al. The pathology of arteriovenous malformations of the brain treated by embolotherapy. II. Results of embolization with multiple agents. Neuroradiol 1993;35: 468-74
45. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70-74
46. Sato TN, Qin Y, Kozak CA, Audus KL. Tie-1 and Tie-2 define a new class of putative receptor tyrosine kinases expressed in early embryonic vascular system. Proc Natl Acad Sci USA 1993;90: 9355-58
47. Wernert N, Raes MB, Lassalle P, et al. c-ets 1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans. Am J Pathol 1992;140:119-27
48. Kola I, Brookes S, Green AR, et al. The Ets 1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci USA 1993;90: 7588-92
49. Alvarez JA, Baird A, Tatum A, et al. Localization of basic fibroblast growth factor and vascular endothelial growth factor in human glial neoplasms. Mod Pathol 1992;5:303-7
50. Ijichi A, Sakuma S, Tofilon PJ. Hypoxia-induced vascular endothelial growth factor expression in normal rat astrocyte cultures. Glia 1995;14:87-93
51. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-45